chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Tenderness
Clinical narrative: Patient reports 7hrs after Pfizer booster that she noticed a red circle and some inflammation and pain to upper arm area . Approx. 3 finger widths from acromion process... No itching no anaphylaxis. Still 2 days later area present with redness more spread out still localized 1.5 in size appr noted to be faded on all edges. Some tenderness to area noted. Some warmness but no streaking. Patient reports feeling completely fine. Discussed close monitoring.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Abdominal pain upper, Alanine aminotransferase normal, Anion gap decreased, Aspartate aminotransferase normal
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Basophil count normal, Basophil percentage decreased, Blood albumin decreased, Blood alkaline phosphatase normal, Blood bicarbonate decreased
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blood bilirubin decreased, Blood calcium decreased, Blood chloride normal, Blood creatinine normal, Blood glucose increased
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blood potassium decreased, Blood sodium decreased, Blood triglycerides increased, Blood urea decreased, Brain natriuretic peptide normal
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, Chest X-ray normal, Computerised tomogram abdomen abnormal, Differential white blood cell count abnormal
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Eosinophil count normal, Eosinophil percentage decreased, Full blood count abnormal, Glomerular filtration rate decreased, Haematocrit decreased
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Immature granulocyte count, Inflammation, Lymphocyte count normal, Lymphocyte percentage increased
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal, Mean platelet volume increased, Metabolic function test abnormal
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Monocyte count normal, Monocyte percentage, Nausea, Neutrophil count decreased, Neutrophil percentage decreased
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Nucleated red cells, Platelet count normal, Protein total decreased, Red blood cell count decreased, Red cell distribution width increased
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tachycardia, White blood cell count decreased
Clinical narrative: Hospitalized (11.5.21 -discharged 11/14/21; COVID-19 positive (11.4.21); Fully vaccinated  HOSPITAL COURSE: Patient is a 36 y.o. female with a known history of COPD, asthma, recurrent pancreatitis related to hypertriglyceridemia, type 2 diabetes uncontrolled, anxiety, depression, PTSD and morbid obesity who presented to the ED with three days of epigastric pain on 11/4/21. In the ED, she was tachycardic with VS otherwise stable. Labs notable for Na 127, glucose 318, TG 2540. COVID PCR was positive. CXR showed no acute pathology. CT abd/pelvis showed inflammatory process in the distal duodenum, pancreas head and uncinate process with a fluid collection. Patient was given 1L IVF and admitted for abdominal pain 2/2 possible pancreatitis.   Upon admission, she was evaluated by the GI team who recommended treatment of hypertriglyceridemia with insulin gtt as well as ongoing IV hydration.  She remained on insulin drip for several days with improvement triglycerides. She was converted to BBI per DGMS recs and blood glucose remained stable. At discharge DGMS recommending resuming home insulin and oral antihyperglycemic regimen.   Regarding COVID, patient received monoclonal antibodies while on room air.  She was thought to be nearing discharge when she began to require supplemental oxygen up to max of 6L.  There was concern for hypervolemia due to the amount of IV fluids she had received, but BNP was normal and CXR without evidence of pulmonary vascular congestion.  Patient was started on remdesivir and Decadron. Completed 4 days of therapy. Oxygen was able to be weaned off completely during the day but she continued having mild desats at night on overnight oximetry study. She is in process of being diagnosed w/ OSA and has follow up sleep study scheduled. Home Oxygen was prescribed for NC 2L at night. Patient discharged with instructions to follow up with DGMS and PCP outpatient. Patient in agreement with discharge plan and discharged in stable condition.   CONSULTS / RECOMMENDATION:     Consult Orders (From admission, onward)                   CONSULT TO DIABETES & ENDOCRINOLOGY      Provider:   DO        CONSULT TO GI      Provider:   MD
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Patient was given 0.2 ml of the Pfizer Covid 19 vaccination 12 and up formulation, instead of the 5-11 year old formulation.  When realized, Provider called to check on patient 11/22/2021-mother reports no adverse reaction, only soreness in arm where vaccine was given.  No other symptoms.  Mother advised according to CDC guidelines that second dose is optional and mom elects to proceed with second dose.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Pruritus, Pulmonary function test normal, Rash, SARS-CoV-2 test negative
Clinical narrative: It started a couple days after the dose. I started getting really extreme shortness of breath. I was struggling to take good full breaths that were satisfactory. I was gasping for air sometimes every few minutes. It would happen a lot the first few days every few minutes and would get worse in the evenings. It slowly tapered off after a few weeks. I still have that shortness of breath every now and then. First dose I also got a large rash on my left arm. It happened 6 days after the 1st dose then went away. After I got my 2nd vaccine, my left arm started itching again and then it went away. Office visits that were follow up after the first dose doctor visits June 23. Shortness of breath is still there occasionally and lighter but recovered.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Erythema, Herpes zoster, Injection site pain, Injection site swelling, Periorbital pain
Clinical narrative: 2/19/21 Second COVID Pfizer shot.  6/20/21 Severe shingles develops over and around right eye and forehead.  Patient hospitalized for a week to receive antiviral medication via vein. After hospital release, five months later, patient has severe swelling/pain at the site and continues receive physical therapy massage.    11/12/2021 Third COVID Pfizer shot given. One day later: The area around patients right eye where the shingles area occurred previously shows renewed redness, swelling and pain. This continues without relief as of the date of this report 11/22/2021. The patients physical therapist has noted the recurrence as well.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Periorbital swelling, Symptom recurrence
Clinical narrative: 2/19/21 Second COVID Pfizer shot.  6/20/21 Severe shingles develops over and around right eye and forehead.  Patient hospitalized for a week to receive antiviral medication via vein. After hospital release, five months later, patient has severe swelling/pain at the site and continues receive physical therapy massage.    11/12/2021 Third COVID Pfizer shot given. One day later: The area around patients right eye where the shingles area occurred previously shows renewed redness, swelling and pain. This continues without relief as of the date of this report 11/22/2021. The patients physical therapist has noted the recurrence as well.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Asthenia, Cough, Vaccine breakthrough infection
Clinical narrative: This case meets criteria for vaccine breakthrough review. SxS include 3 days PTA abdominal pain, cough, generalized weakness.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Rheumatoid factor positive
Clinical narrative: COVID - 19 RA positive post vaccination
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Lymphadenopathy, Swelling
Clinical narrative: swelling, and redness left arm with supraclavicular lymphadenopathy
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives developed on 11/20 and are still occurring today 11/22
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was accidentally given FLUZONE HD.  No adverse reaction was reported at the time of conversation which occurred a few hours after receiving the vaccination.  Patient was made aware of potential Side effects that the High Dose Flu vaccine is like regular flu vaccine such as headache, soreness at the injection site, muscle aches, and fatigue
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 08/11/2021. PATIENT FULLY VACCINATED 02/27/2021.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: I got a rash of itchy small red bumps, mostly on my ribcage, starting the day after the vaccine and getting worse 2 days after the vaccine.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: LPN who administered the vaccine went into the vial more than 20 times.  No untoward effects to patient arm.  MD was made aware and evaluated the patient.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Hyperhidrosis
Clinical narrative: 5mins post vaccination pt c/o Flushing/sweating and dizziness. Vitals: 99/57, 70, 20, 100%RA, 97.5F -- > 99/61, 71, 100% Pt stable and released from the vaccination site 18mins post vaccination.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received first dose of Moderna vaccine on 5/26/2021 and second dose on 7/14/21. Patient received 3rd dose of Moderna booster by error on 11/19/2021 despite lack of 6 months between time of receiving second dose.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive RA Covid 19 test on screening
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 10/20/2021. PATIENT FULLY VACCINATED ON 02/24/2021.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral swelling
Clinical narrative: arms started swelling/tingling/swimming sensation
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Lip swelling
Clinical narrative: pt had angioedema with significant lip swelling within 24 hours of receiving first dose.
Age: 7.0
Sex: M
Vaccine: DTAP
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: There were no adverse effects, Dtap was given but should have been Tdap as patient was over 6 years but was behind on his vaccines
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Swelling
Clinical narrative: cervical lymphadenopathy swelling 48 hour post vaccine, on same side as vaccine administration
Age: 43.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Screening COVID 19 test RA positive after full vaccination
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Patient is 12 year old pt who received Pediatric dose of Pfizer for ages 5-11.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 11/10/2021. PATIENT FULLY VACCINATED ON 05/08/2021.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Lip swelling, Swelling face, Swollen tongue, Throat irritation
Clinical narrative: Facial swelling: throat itchy, tongue swelling , lip swelling, difficult to swallow. Diphenhydramine 50mg po x1 Epiephrine .5mg im Famotidine: 20 mg po  prednisone; 60 mg po
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Fall, Head injury, Limb injury, X-ray
Clinical narrative: 4/9/21 Loss of balance, trip and fall, impacting right shoulder & upper arm, back of head.
Age: 32.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: screening COVID 19 RA test positive post full vaccination
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 06/01/2021. PATIENT FULLY VACCINATED ON 02/18/2021.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient admitted to hospital as inpatient on 11/18/21 due to abdominal pain. Patient was tested for COVID-19 at Pharmacy prior to admission and had COVID + result of that test which was 11/5/21.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Blood test normal, Breast feeding, Chest discomfort, Dyspnoea
Clinical narrative: First dose after a couple of days, I started feeling the shortness of breath and it started getting worse especially in the evening. I would be gasping for air sometimes and would occur every few minutes throughout the day and eventually tapered off after a couple weeks with it occasionally happening again. As per treatment, I had a visit phone visit 4/29/2021 about shortness of breath and chest tightness. The day after or the day after that, I went to the urgent care, and they did an echocardiogram of my heart. They said everything was fine. I asked if I should see a pulmonologist and the urgent care doctor said sure. 5/5 I went to the pulmonologist, he chatted with me about the symptoms and ran some tests. He prescribed me an inhaler, but I was scared to use it because I was breast feeding. I also did a blood test, and everything was normal with that as well. Complete blood test, D-dimer, and a little anemic I have been for a while. June 23, pulmonary function test normal. I did do a COVID-19 test on 5/7 and it was negative as well. 6 days after the dose, it looked like I had a bite on my arm and spread over the night that turned into a large pink rash. I messaged my dermatologist about it, and they said that it was a normal reaction for the Moderna shot. Went away after a few days.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram normal, Fibrin D dimer normal, Laboratory test, Pulmonary function test normal, Rash
Clinical narrative: First dose after a couple of days, I started feeling the shortness of breath and it started getting worse especially in the evening. I would be gasping for air sometimes and would occur every few minutes throughout the day and eventually tapered off after a couple weeks with it occasionally happening again. As per treatment, I had a visit phone visit 4/29/2021 about shortness of breath and chest tightness. The day after or the day after that, I went to the urgent care, and they did an echocardiogram of my heart. They said everything was fine. I asked if I should see a pulmonologist and the urgent care doctor said sure. 5/5 I went to the pulmonologist, he chatted with me about the symptoms and ran some tests. He prescribed me an inhaler, but I was scared to use it because I was breast feeding. I also did a blood test, and everything was normal with that as well. Complete blood test, D-dimer, and a little anemic I have been for a while. June 23, pulmonary function test normal. I did do a COVID-19 test on 5/7 and it was negative as well. 6 days after the dose, it looked like I had a bite on my arm and spread over the night that turned into a large pink rash. I messaged my dermatologist about it, and they said that it was a normal reaction for the Moderna shot. Went away after a few days.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: First dose after a couple of days, I started feeling the shortness of breath and it started getting worse especially in the evening. I would be gasping for air sometimes and would occur every few minutes throughout the day and eventually tapered off after a couple weeks with it occasionally happening again. As per treatment, I had a visit phone visit 4/29/2021 about shortness of breath and chest tightness. The day after or the day after that, I went to the urgent care, and they did an echocardiogram of my heart. They said everything was fine. I asked if I should see a pulmonologist and the urgent care doctor said sure. 5/5 I went to the pulmonologist, he chatted with me about the symptoms and ran some tests. He prescribed me an inhaler, but I was scared to use it because I was breast feeding. I also did a blood test, and everything was normal with that as well. Complete blood test, D-dimer, and a little anemic I have been for a while. June 23, pulmonary function test normal. I did do a COVID-19 test on 5/7 and it was negative as well. 6 days after the dose, it looked like I had a bite on my arm and spread over the night that turned into a large pink rash. I messaged my dermatologist about it, and they said that it was a normal reaction for the Moderna shot. Went away after a few days.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Condition aggravated, Hyperaesthesia, Nerve conduction studies normal, Neurological examination
Clinical narrative: 5 days after the injection (April 12) I noticed pain/tingling in both hands and both feet. In addition, some places on hands and feet were very sore to the touch. Symptoms increased over the next week; visited primary care Dr on April 21. Symptoms escalated and visited ER on April 24. Consulted with pain specialist May 4, neurologist May 6 and had nerve conductivity tests May 13.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Vitamin B6 increased
Clinical narrative: 5 days after the injection (April 12) I noticed pain/tingling in both hands and both feet. In addition, some places on hands and feet were very sore to the touch. Symptoms increased over the next week; visited primary care Dr on April 21. Symptoms escalated and visited ER on April 24. Consulted with pain specialist May 4, neurologist May 6 and had nerve conductivity tests May 13.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: LPN withdrew greater than 20 doses from a single vial.  No untoward effects to the patient's arm.  MD notified and assessed patient
Age: 8.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: no adverse effects, pt gwas given Dtap but it should have been Tdap as pt is older than 6 years old. She was behind on her vaccines and had not received her 5th dose of dtap prior to this date
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 08/27/2021. PATIENT FULLY VACCINATED ON 03/16/2021.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Deafness, Immediate post-injection reaction, Tinnitus
Clinical narrative: Persistent low frequency tinnitus and hearing loss immediately following vaccination.  Every day, ongoing since vaccination booster was received.
Age: 39.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Disorientation, Dizziness, Extra dose administered, Paraesthesia
Clinical narrative: Client stated, "I was sitting in my chair for 2 minutes and then I began to feel a rush to my head. It felt like a wave of tingling all over my body and I started to feel disoriented for like 10 seconds. I then felt fine but I said to myself I need to get up and let the nurse know." Secondary RN helped transfer client into anti-gravity chair at 12:05 PM. First set of vitals were then taken at that time by Observation RN prior to Co Lead PHN responding to observation room: BP 115/75, pulse 60, O2 SAT 100%, 16 respirations per minute. At 12:08 PM Co Lead PHN advised client to take face mask off and for client to take deep breaths. Client was offered water and snacks but client declined snacks and already had a water bottle. Client stated, "I am not surprised I felt like this after the shot because back when I received my first Janssen shot the next day I felt slight chest tightness while driving. It only lasted for 15 seconds then I felt fine. I am not sure if it was due to the covid-19 vaccine so I didn't feel the need to let my doctor know." Co Lead PHN clarified whether she was short of breath during that experience while driving to which client said "no." Client stated, "I felt like I was gasping for air and not so much choking. It only lasted for 15 seconds while I was driving and I then felt fine." Client then disclosed to Co Lead PHN, "I've had similar experiences with blood draws where I feel like I'm going to faint." Client does not have any medical conditions nor is taking any medications. Client has no history of allergies. Client did state, "I am sensitive to soaps, lotions, and I always take half the dose of any medication." Co Lead PHN observed client to be A&Ox4 throughout entire conversation. Co lead PHN recommended for client to follow up with PCP regarding post vaccination symptoms and to enroll in V-SAFE. Client stated, "I have an appointment with my PCP on Tuesday, I will let them know." At 12:16 PM secondary RN educated the client on when to call 911 or go to urgent care for adverse symptoms of covid-19 vaccination. Client verbalized understanding. Co Lead PHN recommended for client to call a family member to assist the client in driving home to which client declined because she only lives 1 mile away from vaccination site. Co Lead PHN recommended for one last set of vitals after another 10 minutes of monitoring. at 12:27 PM Secondary RN took last set of vitals: BP LA 115/70, pulse 64, O2 SAT 100%. Client expressed she was ready to go home. At 12:31 PM Co Lead PHN walked with client as standby assist towards the exit of vaccination site. Client walked with steady gait and thanked us for assisting her.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, Nucleic acid test, Procalcitonin, SARS-CoV-2 test positive
Clinical narrative: Case was fully vaccinated for Covid by March 2021, then was hospitalized for it in November 2021. Plan: Symptoms 2 weeks prior to hospitalization/test. Treated with remdesivir and dexamethasone Procalcitonin TX w/ ceftriaxone.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Rash, Rash papular, Rash pruritic
Clinical narrative: Rash that is itchy and raised. Starting on arms clearing, starting on head and chest then clearing slightly, currently on stomach, back, legs, arms. Ongoing since 11/1/21.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Incorrect vaccine given for patients age.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Breakthrough COVID-19 infection. Tested positive on 09/02/2021. Patient fully vaccinated on 02/06/2021.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Nausea, Pyrexia
Clinical narrative: patient described a headache starting 4 hours after vaccination. At around 7pm that night fever, sweats, extreme chills and nausea began in addition the the headache. Patient stated these symptoms lasted for about 48 hours.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain, Polymyalgia rheumatica
Clinical narrative: muscle weakness and intense pain. Diagnosed with Poly Myalgia Rheumatica
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Exposure during pregnancy, Human chorionic gonadotropin positive, Ultrasound scan abnormal
Clinical narrative: I was unknowingly pregnant when I received both doses of the Pfizer COVID19 vaccination, estimated date of delivery was June 13, 2022.  I later learned that I experienced a spontaneous abortion at 9 weeks 1 day, as there was no heart beat at 10 weeks 3 days.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: chest discomfort
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Product administered at inappropriate site, Skin warm, Swelling
Clinical narrative: Covid booster shot was given in shoulder joint (bursa) instead of deltoid muscle.  Obviously high injection site 1/2 finger width below acromion process.  Pain, heat, swelling to shoulder joint progressively getting worse over past 5 days, no pain in deltoid muscle.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite
Clinical narrative: Loss of appetite.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: It started the evening after I received my dose, and it was the same experience after I received my second dose in January. I experienced intense epigastric pain that spread to my back all up my back. It lasted for 12 hours, I used over the counter antacid with no effect. The next day I called my primary care, they called in Carafate. Then I went to see my gastrointestinal doctor.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the best-used-date but before expiration date.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Chills, Diarrhoea, Dyspnoea
Clinical narrative: Severe nausea that lasted for 1 week. Profound weakness and fatigue. Chills, loss bowel and very upset stomach. She said she felt like she was going to die. She had shortness of breath. The of being very exhausted.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: Severe nausea that lasted for 1 week. Profound weakness and fatigue. Chills, loss bowel and very upset stomach. She said she felt like she was going to die. She had shortness of breath. The of being very exhausted.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Infection, SARS-CoV-2 test positive
Clinical narrative: BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 09/01/2021. PATIENT FULLY VACCINATED ON 07/02/2021.